Assessing Toxicant Properties of Cigarillo and Hookah Aerosols in Lung Epithelial and Cardiac Cells Through Aerosol Exposure
通过气溶胶暴露评估小雪茄和水烟气溶胶对肺上皮和心肌细胞的毒性特性
基本信息
- 批准号:9976518
- 负责人:
- 金额:$ 63.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-20 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAerosolsAffectAgeAldehydesAortic AneurysmAromatic Polycyclic HydrocarbonsBiological AssayBiological MarkersBloodCarcinogensCardiacCardiac MyoblastsCardiopulmonaryCardiovascular systemCell DeathCell LineCellsCharcoalChemicalsChronicChronic Obstructive Airway DiseaseCigar SmokingCigaretteComet AssayComplexCoronary arteryCoronary heart diseaseCotinineCoupledDNA AdductsDNA DamageDNA strand breakDataDevelopmentDiseaseDoseEndothelial CellsEpithelialEpithelial CellsEpitheliumExposure toGasesGene ExpressionGenerationsGrowthHazardous ChemicalsHealthHeritabilityHumanImmuneImmune responseImmune signalingIn VitroInflammationKentuckyLinkLipid PeroxidationLiteratureLungMalignant NeoplasmsMalignant neoplasm of lungMeasuresModelingMolecularMucous body substanceNeutral RedNicotineNitrosaminesOutcomeOxidative StressParticulate MatterPathway interactionsPharmacodynamicsPhysiologicalPoliciesPropertyPulmonary EmphysemaPulmonary Heart DiseaseReactive Oxygen SpeciesReportingResearchRiskSignal TransductionSmokingStandardizationSystemThiobarbituric Acid Reactive SubstancesThymidine KinaseTissuesTobaccoTobacco smokeToxic effectWorkairway epitheliumbronchial epitheliumchemical propertycigarette smokecigarilloscomparativecytokinecytotoxiccytotoxicitydesignepidemiology studyevidence baseexperienceexposed human populationgenotoxicityhazardhookahhuman modelimmunoregulationin vitro Modelinflammatory milieuinsightlung developmentparticlephysical propertypredictive toolsrespiratoryresponsesmoke inhalationstem cellstobacco exposuretobacco productstoxicanttranscriptometranscriptome sequencingtreatment responseuptakewhole genomeyoung adult
项目摘要
Project Summary
Nearly 16% of US young adults ages 18–24 report smoking cigars and a recent review documents
growing evidence linking this product to lung cancer, coronary heart disease, aortic aneurysm and COPD.
Similarly, epidemiological studies link waterpipe tobacco to these same diseases. To date, there are few
studies characterizing these tobacco aerosols with respect to toxicant chemicals, and limited information
regarding effects on target cells with respect to cytotoxicity, genotoxicity, inflammation, and immune
responses. Importantly, no comparative dose response studies to cigarettes have been conducted to study
these endpoints, a research gap that is imperative to address for providing pharmacodynamic outcomes for
these addictive nicotine-containing products. Our research will allow for establishment of strong evidence-
based policies to inform the public of their hazardous properties. The specific aims and research strategy
derive from these research gaps and address two of the scientific domains in the RFA, toxicity and health
effects. As mandated by the FDA, the studies are not mechanistic, but are designed to compare responses
and effects at the cellular level across tobacco products (cigarettes, cigarillos, and hookah). The central
hypothesis of this project is that cigarillo and hookah tobacco products will show significantly greater toxicant
properties and predicted health effects when compared to cigarettes. Building on more than two decades of
experience in characterizing the physical and chemical properties of complex aerosols, Aim 1 will provide the
most comprehensive characterization to date for hazardous chemicals linked to cancer and cardiopulmonary
diseases in aerosols from eight common hookah tobacco products. The extensive dose response
characterization of the TPM generated from aerosols of these products using standardized cytotoxicity,
mutagenicity, and genotoxicity assays will also provide key insight regarding the potency of these products for
causing toxicity and harm relative to our studies just completed for cigarettes and cigarillos. Through a battery
of short-term assays and biomarkers (cytokines, DNA adducts), Aim 2 will critically evaluate complete and
fractionated (particles and gas only) aerosols generated from cigarettes, cigarillos, and hookah products in
lung epithelial cells, cardiac cells, and endothelial cells. A cumulative hazard score for each product will be
derived. Aim 3 focuses on adaptive responses of lung epithelial cells in response to treatment of cells for 4-wk
with complete aerosols from one each of these tobacco products. Outcomes from results will include changes
in cytokine levels and pathway alterations that may impact immune response, signaling, invasion, and growth.
These studies should inform generalized responses of the large and small airway epithelium that could
demonstrate a pro-inflammatory environment and/or altered immune signaling documented in the literature to
be associated with mucous hypersecretion and/or emphysema.
项目摘要
近16%的美国18-24岁的年轻人报告吸烟雪茄,最近的一份审查文件显示,
越来越多的证据表明该产品与肺癌、冠心病、主动脉瘤和COPD有关。
同样,流行病学研究将水烟与这些疾病联系起来。迄今为止,
关于有毒化学物质的烟草气溶胶特征的研究,以及有限的信息
关于细胞毒性、遗传毒性、炎症和免疫方面对靶细胞的影响,
应答重要的是,没有进行香烟的比较剂量反应研究,
这些终点,这是一个研究空白,必须解决提供药效学结果,
这些含有尼古丁的成瘾产品。我们的研究将提供有力的证据-
根据政策,告知公众其危险属性。具体目标和研究策略
从这些研究空白中得出,并解决RFA中的两个科学领域,毒性和健康
方面的影响.根据FDA的要求,这些研究不是机械性的,而是为了比较反应
以及烟草制品(香烟、小雪茄和水烟)在细胞水平上的影响。中央
该项目假设是,小雪茄和水烟烟草产品将显示出明显更大的毒性,
与香烟相比,它的特性和预测的健康影响。在20多年来
在表征复杂气溶胶的物理和化学性质方面的经验,目标1将提供
迄今为止,与癌症和心肺功能相关的危险化学品的最全面表征
八种常见的水烟烟草产品气溶胶中的疾病。广泛的剂量反应
使用标准化细胞毒性表征这些产品的气溶胶产生的TPM,
致突变性和遗传毒性试验也将提供关于这些产品的效力的关键见解,
相对于我们刚刚完成的香烟和小雪茄的研究,通过电池
短期检测和生物标志物(细胞因子,DNA加合物),目标2将严格评估完整和
香烟、小雪茄和水烟产品产生的分级(仅颗粒和气体)气溶胶,
肺上皮细胞、心肌细胞和内皮细胞。每种产品的累积危险评分将为
推导目的3关注肺上皮细胞对细胞处理4周的适应性反应
每种烟草制品都有完整的气雾剂。结果将包括变化
细胞因子水平和途径改变可能影响免疫应答、信号传导、侵袭和生长。
这些研究应该告知大气道上皮和小气道上皮的一般性反应,
证明文献中记载的促炎环境和/或改变的免疫信号传导,
与粘液分泌过多和/或肺气肿有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven A Belinsky其他文献
Early menopause and hormone therapy as determinants for lung health outcomes: a secondary analysis using the PLCO trial.
早期绝经和激素治疗作为肺部健康结果的决定因素:使用 PLCO 试验的二次分析。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:10
- 作者:
Xiaochun Gai;Yue Feng;Tessa M Flores;Huining Kang;Hui Yu;Kimberly K Leslie;Yiliang Zhu;Jennifer A Doherty;Yan Guo;Steven A Belinsky;Linda S Cook;Shuguang Leng - 通讯作者:
Shuguang Leng
Steven A Belinsky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven A Belinsky', 18)}}的其他基金
Aerosolized Epigenetic Therapy for Metastatic Lung Cancer
雾化表观遗传疗法治疗转移性肺癌
- 批准号:
10760630 - 财政年份:2023
- 资助金额:
$ 63.86万 - 项目类别:
Assessing Toxicant Properties and Health Effects of Cigarillo and Hookah Tobacco Aerosols in Rats
评估小雪茄和水烟气溶胶对大鼠的毒性特性和健康影响
- 批准号:
10413991 - 财政年份:2020
- 资助金额:
$ 63.86万 - 项目类别:
DNA Repair Capacity Assays for Lung Disease Risk Assessment
用于肺部疾病风险评估的 DNA 修复能力测定
- 批准号:
10470762 - 财政年份:2018
- 资助金额:
$ 63.86万 - 项目类别:
Assessing Toxicant Properties of Cigarillo and Hookah Aerosols in Lung Epithelial and Cardiac Cells Through Aerosol Exposure
通过气溶胶暴露评估小雪茄和水烟气溶胶对肺上皮和心肌细胞的毒性特性
- 批准号:
9788459 - 财政年份:2018
- 资助金额:
$ 63.86万 - 项目类别:
DNA Repair Capacity Assays for Lung Disease Risk Assessment
用于肺部疾病风险评估的 DNA 修复能力测定
- 批准号:
10296957 - 财政年份:2018
- 资助金额:
$ 63.86万 - 项目类别:
DNA Repair Capacity Assays for Lung Disease Risk Assessment
用于肺部疾病风险评估的 DNA 修复能力测定
- 批准号:
9768991 - 财政年份:2018
- 资助金额:
$ 63.86万 - 项目类别:
Deposition Profile and Toxicology of E-Cigarettes in the Oral Epithelium
电子烟在口腔上皮细胞中的沉积概况和毒理学
- 批准号:
9117092 - 财政年份:2016
- 资助金额:
$ 63.86万 - 项目类别:
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy
吸入 Vidaza 用于靶向表观遗传肺癌治疗
- 批准号:
10208793 - 财政年份:2016
- 资助金额:
$ 63.86万 - 项目类别:
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy
吸入 Vidaza 用于靶向表观遗传肺癌治疗
- 批准号:
10296534 - 财政年份:2016
- 资助金额:
$ 63.86万 - 项目类别:
Histone Methyltransferases as a Target for Lung Cancer Prevention
组蛋白甲基转移酶作为肺癌预防的靶点
- 批准号:
8856526 - 财政年份:2014
- 资助金额:
$ 63.86万 - 项目类别:
相似海外基金
AEROSOLS - AIR QUALITY AND HEALTH IMPACT OF PRIMARY SEMI-VOLATILE AND SECONDARY PARTICLES AND THEIR ABATEMENT
气溶胶 - 一次半挥发性颗粒和二次颗粒对空气质量和健康的影响及其消除
- 批准号:
10092043 - 财政年份:2024
- 资助金额:
$ 63.86万 - 项目类别:
EU-Funded
Molecular-level Understanding Of Atmospheric Aerosols (MUOAA 2024); Corsica, France; April 1-5, 2024
对大气气溶胶的分子水平理解(MUOAA 2024);
- 批准号:
2332007 - 财政年份:2024
- 资助金额:
$ 63.86万 - 项目类别:
Standard Grant
TWISTA (The Wide-ranging Impacts of STratospheric smoke Aerosols)
TWISTA(平流层烟雾气溶胶的广泛影响)
- 批准号:
NE/Y000021/1 - 财政年份:2024
- 资助金额:
$ 63.86万 - 项目类别:
Research Grant
TWISTA (The Wide-ranging Impacts of STratospheric smoke Aerosols)
TWISTA(平流层烟雾气溶胶的广泛影响)
- 批准号:
NE/Y000358/1 - 财政年份:2024
- 资助金额:
$ 63.86万 - 项目类别:
Research Grant
Southern Ocean aerosols: sources, sinks and impact on cloud properties
南大洋气溶胶:来源、汇以及对云特性的影响
- 批准号:
DP240100389 - 财政年份:2024
- 资助金额:
$ 63.86万 - 项目类别:
Discovery Projects
An AI-driven clinical washbasin unit that automatically disinfects pathogens, reduces aerosols and decreases healthcare-acquired infections by 70%
%20人工智能驱动%20临床%20洗脸盆%20单位%20%20自动%20消毒%20病原体,%20减少%20气溶胶%20和%20减少%20医疗保健获得性%20感染%20by%2070%
- 批准号:
83001507 - 财政年份:2023
- 资助金额:
$ 63.86万 - 项目类别:
Innovation Loans
Cloudbusting with JWST: characterising aerosols, aurorae and chemistry in substellar atmospheresto the water cloud regime
使用 JWST 进行云消除:描述水云状态下恒星大气中的气溶胶、极光和化学成分
- 批准号:
ST/X001091/1 - 财政年份:2023
- 资助金额:
$ 63.86万 - 项目类别:
Research Grant
INvestigating Home water and Aerosols' Links to opportunistic pathogen Exposure (INHALE): do consumer decisions impact pathogen exposure and virulence?
调查家庭用水和气溶胶与机会性病原体暴露(吸入)的联系:消费者的决定是否会影响病原体暴露和毒力?
- 批准号:
2326096 - 财政年份:2023
- 资助金额:
$ 63.86万 - 项目类别:
Standard Grant
Bioactivated Aerosols for Combustion Product Capture
用于燃烧产物捕获的生物活性气溶胶
- 批准号:
10080253 - 财政年份:2023
- 资助金额:
$ 63.86万 - 项目类别:
Small Business Research Initiative














{{item.name}}会员




